Two New Studies Cite Heart Risk in GlaxoSmithKline's Avandia
WSJ -- Two new studies released Monday said the diabetes drug Avandia is unsafe, heating up a controversy about a drug linked in a number of studies to an increased risk of heart attack and heart failure.